Staging of colorectal cancers based on elastic lamina invasion.


Journal

Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547

Informations de publication

Date de publication:
03 2019
Historique:
received: 31 05 2018
revised: 17 10 2018
accepted: 24 10 2018
pubmed: 16 11 2018
medline: 26 11 2019
entrez: 16 11 2018
Statut: ppublish

Résumé

Peritoneal involvement in colorectal cancer (CRC) has prognostic significance and is an important parameter in pathologic tumor staging. Restaging of tumors based on peritoneal elastic lamina invasion (ELI) has prognostic significance in CRCs classified as pathologic stage 3 tumors without regional lymph node metastasis (pT3N0). However, limited data on the significance of ELI in patients with node-positive disease are available. We applied elastic stain to one block per case for 141 consecutive patients with pT3N1M0 CRCs. The elastic lamina was identified in only 62 cases (44%), of which 39 (27.6%) displayed ELI. The ELI+ group was associated with a significantly worse ( 0.;P < .001) 5-year disease-free survival (5-year DFS, 48.7%) and 5-year overall survival (5-year OS, 61.4%) compared with the ELI- (5-year DFS, 73.9%; OS, 95.7%) and no elastic lamina (5-year DFS, 79.5%; OS, 85.7%) groups. Comparison of outcomes in cases with pT3N1M0 with peritoneal ELI and pT4aN1M0 tumors (based on the original pathologic assessment without the use of elastic staining) showed no significant differences in the 5-year DFS (P = .47) and OS (P = .65). These findings suggest that ELI is a significant prognostic marker and that elastic staining should be considered for routine use in pT3 CRCs in a node-positive setting. Upstaging of pT3 tumors with ELI should be considered in the future iterations of the American Joint Committee on Cancer/Union for International Cancer Control tumor-node-metastasis staging system for CRC.

Identifiants

pubmed: 30439370
pii: S0046-8177(18)30416-7
doi: 10.1016/j.humpath.2018.10.019
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

44-49

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Wen-Yih Liang (WY)

Department of Pathology and Laboratory Medicine, Veterans General Hospital-Taipei, Taipei, Taiwan, 112 ROC; National Yang-Ming University School of Medicine, Taipei, Taiwan, 112 ROC. Electronic address: wyliang@vghtpe.gov.tw.

Yu-Chen Wang (YC)

Department of Pathology and Laboratory Medicine, Veterans General Hospital-Taipei, Taipei, Taiwan, 112 ROC; Department of Pathology, Show Chwan Memorial Hospital, Changhua, Taiwan, 500 ROC.

Chih-Yi Hsu (CY)

Department of Pathology and Laboratory Medicine, Veterans General Hospital-Taipei, Taipei, Taiwan, 112 ROC; National Yang-Ming University School of Medicine, Taipei, Taiwan, 112 ROC.

Shung-Haur Yang (SH)

National Yang-Ming University School of Medicine, Taipei, Taiwan, 112 ROC; Division of Colon and Rectal Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan, 112 ROC; Department of Surgery, National Yang-Ming University Hospital, Yilan, Taiwan, 260 ROC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH